Top 26 PathoQuest investors
The most complete profiles first. Showing 26 of 26.
Philippe PeltierVerified
Venture Capital, Investor · France
SeedHealth CareHospitalsCRMEducationPortfolio: Implanet, AM Pharma, FeetMe, Advanced Perfusion Diagnostics and 36 more
Verified email available
Thierry LaugelVerified
Venture Capital, Private Equity Firm, Investor · France
SeedHealth CareHospitalsCRMEducationPortfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more
Verified email available
Vanessa MalierVerified
Venture Capital, Investor · France
SeedHealth CareHospitalsCRMEducationPortfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more
Verified email available
Bao DinhVerified
Private Equity Firm · France
Health CareWearablesE-commercePaymentsPortfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more
Contact details available
Christophe SimonVerified
Private Equity Firm · France
Health CareWearablesE-commercePaymentsPortfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more
Contact details available
Eric GallerneVerified
Private Equity Firm · France
Health CareWearablesE-commercePaymentsPortfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more
Contact details available
Luc MaruendaVerified
Private Equity Firm · France
Health CareWearablesE-commercePaymentsPortfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more
Verified email available
Matthieu BaretVerified
Private Equity Firm · France
Health CareWearablesE-commercePaymentsPortfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more
Verified email available
Nicolas DebockVerified
Private Equity Firm · France
Health CareWearablesE-commercePaymentsPortfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more
Verified email available
Nicolas NedelecVerified
Private Equity Firm · France
Health CareWearablesE-commercePaymentsPortfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more
Verified email available
Peter SteinVerified
Venture Capital · Netherlands
Health CareGeneticsLife ScienceArtificial Intelligence (AI)Portfolio: Caresyntax, Collagen Solutions, Medical Vision, Stanmore Implants Worldwide and 10 more
Verified email available
Robin RivatonVerified
Private Equity Firm · France
Health CareWearablesE-commercePaymentsPortfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more
Verified email available
Amine MAROUF
Venture Capital, Private Equity Firm, Investor · France
SeedHealth CareHospitalsCRMEducationPortfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more
Contact details available
Annette Fainbloom
Venture Capital, Private Equity Firm, Investor · France
Series BHealth CareWearablesE-commercePaymentsPortfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more
Contact details available
Hadrien Bouchez
Venture Capital, Private Equity Firm, Investor · Netherlands
SeedHealth CareHospitalsCRMEducationPortfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more
Contact details available
Matthieu B.
Venture Capital, Private Equity Firm, Investor · France
SeedPre-SeedHealth CareWearablesE-commercePaymentsPortfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more
Contact details available
Nicolas de Loiray
Venture Capital, Private Equity Firm, Investor · France
Series BHealth CareWearablesE-commercePaymentsPortfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more
Contact details available
Sylvain Cascarino
Venture Capital, Private Equity Firm, Investor · France
SeedHealth CareHospitalsCRMEducationPortfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more
Contact details available
Daniel Emersleben
Private Equity Firm · France
Health CareWearablesE-commercePaymentsPortfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more
Contact details available
Florian Zimmermann
Private Equity Firm · Germany
Health CareWearablesE-commercePaymentsPortfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more
Contact details available
Jean Plamondon
Private Equity Firm · France
Health CareWearablesE-commercePaymentsPortfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more
Contact details available
Julien Michaux
Venture Capital · United Kingdom
Health CareGeneticsLife ScienceArtificial Intelligence (AI)Portfolio: Caresyntax, Collagen Solutions, Medical Vision, Stanmore Implants Worldwide and 10 more
Contact details available
Moritz Reuter
Venture Capital · United Kingdom
Health CareGeneticsLife ScienceArtificial Intelligence (AI)Portfolio: Caresyntax, Collagen Solutions, Medical Vision, Stanmore Implants Worldwide and 10 more
Contact details available
Nicolas Chaudron
Private Equity Firm · France
Health CareWearablesE-commercePaymentsPortfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more
Contact details available
Peter Neubeck
Venture Capital, Private Equity Firm · Germany
Health CareHospitalsCRMEducationPortfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more
Contact details available
Thierry Legeais
Private Equity Firm · France
Health CareWearablesE-commercePaymentsPortfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many PathoQuest investors are on Angel Roster?
Angel Roster lists 26 PathoQuest investors. 9 of them (35%) include a verified email address.
What types of investors are they?
The most common investor types are Private Equity Firms (21) and Venture Capital Firms (13). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do PathoQuest investors invest in?
Among those that list a stage, the most common are Seed (7), Series B (2) and Pre-Seed (1).
Where are PathoQuest investors based?
Most are based in France (20), Germany (2) and the United Kingdom (2).
Which companies have PathoQuest investors backed?
The most-backed portfolio companies among them are FeetMe (23), Minoryx Therapeutics (23), Sensome (23), Corlieve Therapeutics (23) and Ermium Therapeutics (23).
How do I contact PathoQuest investors?
Create a free Angel Roster account to search and filter all 26, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.